BETA: Please send your feedback!
Corcept Therapeutics
CORT:NAS
Pharmaceuticals: Other
$1.57bn
SMALL cap
$13.85
(-0.04%)
0.00%
since start of 2019
20.36
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 1998
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Joseph K. Belanoff, MD | President, Chief Executive Officer, Director & MD | Male |
| Robert S. Fishman, MD | Chief Medical Officer | Male |
| Susan P. Rinne | Vice President-Corporate Regulatory Affairs | Female |
| David B. Singer, MBA | Founder | Male |
| James N. Wilson, MBA | Chairman | Male |
| Gary Charles Robb | Secretary & Chief Financial Officer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 3
Corcept Therapeutics - Competitors and Related Companies
How Corcept Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Corcept Therapeutics
CORT:NAS
Pharmaceuticals: Other
$1.57bn
SMALL cap
$13.85
(-0.04%)
0.00%
since start of 2019
20.36
MannKind
MNKD:NAS
Biotechnology
$255.03mm
SMALL cap
$1.34
(0.04%)
0.14%
since start of 2019
-3.71
Catalyst Biosciences
CBIO:NAS
Biotechnology
$64.17mm
MICRO cap
$5.34
(-0.08%)
-0.36%
since start of 2019
-1.35
Mylan
MYL:NAS
Pharmaceuticals: Generic
$9.52bn
LARGE cap
$18.45
(0.30%)
-0.33%
since start of 2019
307.50
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$343.13bn
MEGA cap
$130.01
(2.00%)
0.02%
since start of 2019
—
Novartis
NOVN-CH:SWX
Pharmaceuticals: Major
$60.48mm
MEGA cap
$2.32
(-0.03%)
1.39%
since start of 2019
-2.42